Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma

Joyce F. Liu, Niya Xiong, Susana M. Campos, Alexi A. Wright, Carolyn Krasner, Susan Schumer, Neil S. Horowitz, Jennifer Veneris, Nabihah Tayob, Stephanie Morrissey,

Journal of Clinical Oncology · 2021 · 187 citations · 33 references

Abstract

Adavosertib monotherapy demonstrated encouraging and durable evidence of activity in women with USC, and further investigation of this agent in this cancer and biomarkers of activity are indicated.

References

33